-
News Agency News Aggregator Journalist/Editor Broking House Others
📈#Results on January 27 and January 28📈 Bajaj Finance, Vedanta, Aarti Drugs, Aditya Birla Sun Life AMC, CMS Info Systems, Glenmark Life Sciences, Godfrey Phillips India, Sterlite Technologies, Zenotech Laboratories
#Results on January 27 Bajaj Finance, Vedanta, Aarti Drugs, Aditya Birla Sun Life AMC, CMS Info Systems, Glenmark Life Sciences, Godfrey Phillips India, Sterlite Technologies, Zenotech Laboratories, and AIA Engineering will be in focus ahead of quarterly earnings on January 27.
AARTIDRUGS - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
#RESULTS #Friday #NiftyWaali 📰 BAJAJ FINANCE #VaydaWaali 📰 VEDANTA #CashWaali 📰 AARTI DRUGS 📰 ADITYA BRILA SUN LIFE AMC 📰 AIA ENGINEERING 📰 CMS INFO 📰 GODFREY PHILLIPS 📰 HIL 📰 STERLITE TECH 📰 TAJ GVK @CNBC_Awaaz #Q3
AARTIDRUGS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Markets are brutal. #AartiInds #AartiSurfactants #AartiDrugs #ValiantOrganics. From being the talk of the town to !. Down 50% from the top.
AARTIDRUGS - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Trade Alerts, Trade Ideas and Crypto 🇺🇸
#GUFICBIO #ZYDUSWELL #FORTIS #AARTIDRUGS #ALKEM #GLAND #BIOCON 📈📉💹📊 via ➡️
GEPL Capital's Stocks to watch. 1⃣ #AARTIDRUGS 2⃣ #SHLIPAMED 3⃣ #SUVENPHAR 4⃣ #CCL 5⃣ #LATENTVIEW #StockMarket #Stocks #StockoftheDay
Trade Alerts, Trade Ideas and Crypto 🇺🇸
#LUPIN #LAURUSLABS #ZYDUSLIFE #APOLLOHOSP #FORTIS #AARTIDRUGS #I 📈📉💹📊 via ➡️
Trade Alerts, Trade Ideas and Crypto 🇺🇸
Aarti Drugs Dares To Move Up. 📈📉💹📊 via ➡️
Trade Alerts, Trade Ideas and Crypto 🇺🇸
AARTIDRUGS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
AARTIDRUGS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
AARTIDRUGS - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
AARTIDRUGS - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
#AARTIDRUGS #APCOTEXIND #BAJAJFINSV #BSOFT #birlasoft
#2QWithCNBCTV18 | Aarti Drugs reported a mixed set of Q2 nos. September quarter saw maximum realisations in API+chemicals segments, says CFO Adhish Patil. Tells @_soniashenoy @SumairaAbidi & @PavitraParekh1 that he expects gross contribution to increase going ahead @ekta_batra
#OnCNBCTV18 | Coal & power costs remained high in Q2FY23. Export demand has been good. 15% composite growth is achievable in FY23, says Adhish Patil of Aarti Drugs
#AARTIDRUGS #AMBUJACEM #CLEAN
-